News | January 17, 2026
Miach Orthopaedics’ BEAR implant gains FDA label claim for reduced arthritis risk
The BEAR Implant is the first sports medicine device to carry a label claim related to lowering PTOA risk
The BEAR Implant is the first sports medicine device to carry a label claim related to lowering PTOA risk
Phase 3 study met all primary and secondary endpoints, demonstrating superior convenience, strong efficacy, and excellent safety versus conventional ondansetron injections
The cancellation underscores the regulator’s strict stance against misleading cosmetic claims
The therapy targets the LRRC15 protein and is designed for enhanced tumor penetration and differentiated anti-tumor activity in solid tumors with the highest unmet needs.
The launch of the study was on the occasion of the International Day of Persons with Disabilities
The formulation is backed by over 80 clinical trials and 200 scientific publications
AiMeD noted that proposed GST changes—to either 5% or 18%—both present significant risks requiring carefully nuanced consideration
The company has improved access to quality healthcare for seniors across both urban and rural areas
The request stemmed from a 2024 lawsuit by Rampart alleging Egg Medical had infringed its patent
Star Health Insurance is modernising its claims ecosystem to be future-ready
Subscribe To Our Newsletter & Stay Updated
